<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Module 27 | Lesson 2: PCOS and Insulin Resistance: A Hormonal Deep Dive</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Hormonal Health */
        .module-header {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #6d28d9;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #6d28d9;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #8b5cf6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #6d28d9;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #4c1d95;
            margin: 30px 0 15px 0;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 600;
        }

        .stat-highlight {
            color: #6d28d9;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e5e5;
        }

        .case-study-header {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #4b5563;
            border-bottom: 2px solid #e5e5e5;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #6d28d9;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f3f4f6;
            border-radius: 8px;
            border-left: 4px solid #6d28d9;
        }

        .references-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            margin-top: 40px;
            font-size: 14px;
            color: #4b5563;
        }

        .takeaways-box {
            background: #f5f3ff;
            border-left: 5px solid #6d28d9;
            padding: 25px;
            margin: 40px 0;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 27: Specialty Applications</p>
            <h1 class="lesson-title">L2: PCOS and Insulin Resistance: A Hormonal Deep Dive</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">The S.T.A.B.L.E. Methodâ„¢</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#pathophysiology"><span class="section-num">1</span>The IR-PCOS Feedback Loop</a></li>
                <li><a href="#phenotypes"><span class="section-num">2</span>The Four PCOS Phenotypes</a></li>
                <li><a href="#screening"><span class="section-num">3</span>Screen & Assess (S) for PCOS</a></li>
                <li><a href="#nutrition"><span class="section-num">4</span>Transform Nutrition (T): Inositols</a></li>
                <li><a href="#hormones"><span class="section-num">5</span>Balance (B): The Androgen Axis</a></li>
                <li><a href="#syncing"><span class="section-num">6</span>Cycle-Syncing Blood Sugar</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the pathophysiology of the "vicious cycle" between hyperinsulinemia and hyperandrogenism.</li>
                <li>Identify the four clinical phenotypes of PCOS and their unique metabolic risks.</li>
                <li>Learn to interpret specialty markers, including LH:FSH ratios and HOMA-IR, within the <span class="highlight">S.T.A.B.L.E. Methodâ„¢</span>.</li>
                <li>Apply cycle-syncing strategies to manage insulin sensitivity fluctuations across the menstrual cycle.</li>
                <li>Design targeted nutritional interventions using anti-inflammatory protocols and myo-inositol.</li>
            </ul>
        </div>

        <h2 id="pathophysiology">1. The Pathophysiology of the PCOS-IR Feedback Loop</h2>
        <p>Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting approximately <span class="stat-highlight">8% to 13%</span> of women worldwide. While often categorized as a reproductive issue, PCOS is fundamentally a <span class="highlight">metabolic-hormonal feedback loop</span> driven by insulin resistance.</p>
        
        <p>In women with PCOS, insulin resistance is not merely a consequence of weight; it is often intrinsic. A 2019 meta-analysis found that <span class="stat-highlight">75% of lean women</span> and <span class="stat-highlight">95% of overweight women</span> with PCOS exhibit some degree of insulin resistance. The mechanism is a "two-way street":</p>
        
        <ul>
            <li><strong>Hyperinsulinemia drives Hyperandrogenism:</strong> High levels of circulating insulin stimulate the <span class="highlight">theca cells</span> of the ovaries to produce excess testosterone. Furthermore, insulin suppresses the liver's production of <span class="highlight">Sex Hormone Binding Globulin (SHBG)</span>, leaving more "free" testosterone available to cause symptoms like hirsutism and acne.</li>
            <li><strong>Hyperandrogenism drives Insulin Resistance:</strong> Excess androgens promote the accumulation of visceral adipose tissue (fat around the organs). This visceral fat is metabolically active and secretes inflammatory cytokines that further impair insulin signaling.</li>
        </ul>

        <h2 id="phenotypes">2. The Four Distinct Phenotypes of PCOS</h2>
        <p>The Rotterdam Criteria are used to diagnose PCOS, requiring two out of three: Hyperandrogenism, Ovulatory Dysfunction, and Polycystic Ovaries on ultrasound. However, from a blood sugar coaching perspective, we must distinguish between the <span class="highlight">phenotypes</span> to tailor the <span class="highlight">S.T.A.B.L.E. Methodâ„¢</span>.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Phenotype</th>
                        <th>Clinical Features</th>
                        <th>Metabolic Risk Profile</th>
                        <th>Coaching Focus</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Type A (Classic)</strong></td>
                        <td>Hyperandrogenism + Ovulatory Dysfunction + PCO</td>
                        <td>Highest IR, high risk of Type 2 Diabetes & CVD.</td>
                        <td>Aggressive Insulin Sensitization (T & A)</td>
                    </tr>
                    <tr>
                        <td><strong>Type B (Hyperandrogenic)</strong></td>
                        <td>Hyperandrogenism + Ovulatory Dysfunction</td>
                        <td>High IR, significant visceral fat accumulation.</td>
                        <td>Androgen Balance & Lipid Management (B)</td>
                    </tr>
                    <tr>
                        <td><strong>Type C (Ovulatory)</strong></td>
                        <td>Hyperandrogenism + PCO</td>
                        <td>Moderate IR; often presents in "Lean PCOS."</td>
                        <td>Inflammation & Stress Management (L)</td>
                    </tr>
                    <tr>
                        <td><strong>Type D (Non-Androgenic)</strong></td>
                        <td>Ovulatory Dysfunction + PCO</td>
                        <td>Lowest IR; often driven by hypothalamic factors.</td>
                        <td>Nutrient Density & Circadian Rhythms (L)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="screening">3. Screen & Assess (S): Interpreting Clinical Markers</h2>
        <p>When working with a PCOS client, the standard HbA1c may appear normal (e.g., 5.2%) while the client is suffering from profound metabolic dysfunction. As an AccrediPro Coach, you must look deeper into the <span class="highlight">Screen & Assess (S)</span> phase.</p>

        <h3>Key Markers for the PCOS Specialist:</h3>
        <ul>
            <li><strong>LH:FSH Ratio:</strong> In a healthy cycle, Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH) are roughly 1:1. In PCOS, the ratio is often <span class="stat-highlight">2:1 or 3:1</span>. High LH stimulates androgen production, while low FSH prevents follicle maturation.</li>
            <li><strong>Fasting Insulin & HOMA-IR:</strong> This is the "Gold Standard" for PCOS. A fasting insulin above <span class="stat-highlight">7 ÂµIU/mL</span> in a PCOS client suggests significant IR, even if glucose is normal.</li>
            <li><strong>SHBG (Sex Hormone Binding Globulin):</strong> Low SHBG is a primary marker for hyperinsulinemia. Increasing SHBG is a key success metric in the <span class="highlight">Balance Hormones (B)</span> phase.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The "Normal A1c" Trap</p>
                    <p class="subtitle">Client: Elena, Age 28</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena - Phenotype A</h4>
                        <p>Symptoms: Weight gain (central), adult acne, 45-day cycles.</p>
                    </div>
                </div>
                <p><strong>Initial Screening (S):</strong> HbA1c: 5.1% (Optimal), Fasting Glucose: 92 mg/dL. Elena's GP told her she was "fine." However, her <span class="highlight">Fasting Insulin was 22 ÂµIU/mL</span>, yielding a <span class="highlight">HOMA-IR of 5.0</span> (Severe Resistance).</p>
                <p><strong>Intervention:</strong> We applied the <span class="highlight">T: Transform Nutrition</span> protocol focusing on a 40:1 Myo-inositol to D-chiro-inositol ratio and a 30% carbohydrate limit.</p>
                <p><strong>Outcome:</strong> Within 12 weeks, Fasting Insulin dropped to 9 ÂµIU/mL, her cycle shortened to 31 days, and her acne cleared significantly. This illustrates why A1c is insufficient for PCOS assessment.</p>
            </div>
        </div>

        <h2 id="nutrition">4. Transform Nutrition (T): Anti-Inflammatory Protocols & Inositols</h2>
        <p>In PCOS, nutrition is not just about calories; it is about <span class="highlight">signal transduction</span>. Because PCOS is a state of chronic low-grade inflammation, the <span class="highlight">T: Transform Nutrition</span> phase must prioritize anti-inflammatory fats and specific micronutrients.</p>

        <h3>The Role of Myo-Inositol</h3>
        <p>Inositols are "secondary messengers" for insulin. Women with PCOS often have a defect in the enzyme that converts Myo-inositol (MI) to D-chiro-inositol (DCI). This leads to an MI deficiency in the ovaries, which impairs egg quality and ovulation.</p>
        <p>A 2021 meta-analysis of 26 randomized controlled trials (n=1,639) showed that <span class="highlight">Myo-inositol supplementation</span> was as effective as Metformin in improving insulin sensitivity, with significantly fewer side effects. The clinical "sweet spot" is a <span class="stat-highlight">40:1 ratio</span> of MI to DCI, mimicking the physiological ratio found in plasma.</p>

        <h3>Nutritional Pillars for PCOS:</h3>
        <ol>
            <li><strong>The Fiber Matrix:</strong> Aim for 35g+ of fiber daily to assist in the excretion of excess metabolized estrogens and androgens.</li>
            <li><strong>Protein Leverage:</strong> PCOS clients often have higher levels of ghrelin (the hunger hormone). High protein (1.2â€“1.5g/kg) is essential to stabilize the "hunger-satiety axis" (Module 4).</li>
            <li><strong>Anti-Inflammatory Fats:</strong> Prioritize Omega-3s (EPA/DHA) which have been shown to reduce testosterone levels in PCOS women by <span class="stat-highlight">18-25%</span> over 6 months.</li>
        </ol>

        <h2 id="hormones">5. Balance (B): Addressing Androgen Excess and Visceral Fat</h2>
        <p>As discussed in the previous module on Adiponectin, visceral fat acts as an independent endocrine organ. In PCOS, androgens encourage fat to store in the <span class="highlight">intra-abdominal region</span> rather than the hips and thighs.</p>
        
        <p>This creates a "Lipid-Insulin Loop." Visceral fat is more resistant to the anti-lipolytic effects of insulin, meaning it constantly leaks free fatty acids into the portal vein, which travels directly to the liver, causing <span class="highlight">hepatic insulin resistance</span>. This is why many PCOS clients struggle with "stubborn" midsection weight even when eating "clean."</p>

        <div class="alert-box info">
            <p class="alert-label">Practitioner Note</p>
            <p>To break the androgen-fat axis, movement (A: Activate Movement) must include resistance training. Muscle tissue is the primary site for glucose disposal. Increasing lean mass improves the LH:FSH ratio indirectly by lowering systemic insulin levels.</p>
        </div>

        <h2 id="syncing">6. Cycle-Syncing Blood Sugar Management</h2>
        <p>A major advancement in blood sugar coaching for women is <span class="highlight">Cycle-Syncing</span>. Insulin sensitivity is not static; it fluctuates based on the dominance of estrogen and progesterone.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Phase</th>
                        <th>Hormonal State</th>
                        <th>Insulin Sensitivity</th>
                        <th>Coaching Strategy</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Follicular (Days 1-14)</strong></td>
                        <td>Estrogen Rising</td>
                        <td><span class="stat-highlight">Highest</span></td>
                        <td>Higher carb tolerance. Ideal for HIIT and heavy lifting.</td>
                    </tr>
                    <tr>
                        <td><strong>Ovulation</strong></td>
                        <td>Estrogen Peak</td>
                        <td>Stable</td>
                        <td>Focus on fiber to clear estrogen surge.</td>
                    </tr>
                    <tr>
                        <td><strong>Luteal (Days 15-28)</strong></td>
                        <td>Progesterone Dominant</td>
                        <td><span class="stat-highlight">Lowest</span></td>
                        <td>Lower carb tolerance. Increase healthy fats and magnesium. Focus on LISS movement.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>During the <strong>Luteal Phase</strong>, progesterone causes a natural rise in core body temperature and a <span class="stat-highlight">10-15% increase</span> in metabolic rate. However, it also induces mild insulin resistance. If a PCOS client maintains the same high-carb intake during the luteal phase, they will likely experience significant glucose spikes and increased cravings.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the PCOS-Insulin connection.</p>
            
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">Why does hyperinsulinemia lead to symptoms like hirsutism (excess hair growth) in women with PCOS?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Insulin acts directly on the ovarian theca cells to stimulate androgen (testosterone) production. Additionally, insulin suppresses the liver's production of SHBG (Sex Hormone Binding Globulin). Lower SHBG means more "free" testosterone is circulating in the blood, which binds to receptors in hair follicles and skin, causing hirsutism and acne.
                </div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">During which phase of the menstrual cycle is a client with PCOS most likely to experience increased insulin resistance and cravings?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The Luteal Phase. Progesterone dominance naturally decreases insulin sensitivity. For a PCOS client already struggling with IR, this phase can lead to significant glycemic variability, necessitating a shift toward lower-glycemic, higher-fat meals and increased magnesium support.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>The Vicious Cycle:</strong> Insulin drives androgens, and androgens drive visceral fat, which creates more insulin resistance.</li>
                <li><strong>Beyond HbA1c:</strong> Fasting insulin and the LH:FSH ratio are more sensitive markers for PCOS metabolic health than glucose-only markers.</li>
                <li><strong>Inositol Synergy:</strong> A 40:1 Myo-inositol to D-chiro-inositol ratio is a clinically proven tool for restoring ovarian insulin signaling.</li>
                <li><strong>Metabolic Flexibility:</strong> Cycle-syncing nutrition (higher carbs in follicular, lower in luteal) helps manage the natural hormonal fluctuations of the menstrual cycle.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ol>
                <li>Cassar et al. (2019). "Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemicâ€“hyperinsulinaemic clamp studies." <em>Human Reproduction Update</em>.</li>
                <li>Unfer et al. (2021). "Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials." <em>Endocrine Connections</em>.</li>
                <li>Teede et al. (2018). "Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome." <em>Fertility and Sterility</em>.</li>
                <li>Barber et al. (2021). "The role of adipose tissue and insulin resistance in PCOS." <em>Reviews in Endocrine and Metabolic Disorders</em>.</li>
                <li>Moghetti et al. (2021). "Insulin Resistance and PCOS: Pathogenesis and Clinical Implications." <em>Frontiers in Endocrinology</em>.</li>
                <li>Giallauria et al. (2008). "Effect of exercise training on insulin resistance and LH:FSH ratio in PCOS." <em>European Journal of Applied Physiology</em>.</li>
            </ol>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Specialized Coaching Methodology.</p>
        </footer>
    </div>
</body>

</html>